22 results
DEFA14A
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy soliciting materials
5:20pm
and closing, you will have the ability to do so, subject to our regular “black out” windows and pre-clearance requirements. At closing, all of your … , at Jonathan.rosin@karunatx.com.
Can I exercise my vested options or sell vested shares before the closing of the transaction?
▪Yes, subject to our regular “black
8-K
EX-99.2
KRTX
Karuna Therapeutics Inc
8 Aug 22
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
6:43am
(%) Male Female 95 (75.4) 31 (24.6) 95 (75.4) 31 (24.6) Race, n (%) Asian Black White Other 2 (1.6) 97 (77.0) 26 (20.6) 1 (0.8) 1 (0.8) 92 (73.0) 31 (24.6
DEF 14A
pt3lb185r
29 Apr 20
Definitive proxy
4:00pm
10-K
ajnv144 cvcmixb3k
24 Mar 20
Annual report
6:32am
424B4
8c81 yna2jvg
21 Nov 19
Prospectus supplement with pricing info
4:02pm
DRS
dmqq8v
28 Oct 19
Draft registration statement
12:00am
10-Q
vahiz
8 Aug 19
Quarterly report
6:31am
424B4
d33f25
28 Jun 19
Prospectus supplement with pricing info
4:03pm
S-1
ivtr3zmxc m7fo
31 May 19
IPO registration
4:03pm
DRS/A
7py0m
22 May 19
Draft registration statement (amended)
12:00am